Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FX3QT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,298
Award facts
- Contract value 100% obligated
- $52,298.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $52,298.24. This firm fixed-price delivery order, awarded on October 21, 2025, represents a non-set-aside competitive award and is set for completion by October 22, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal contracts predominantly with the Defense Logistics Agency for medical supply chain support. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and vaccines. This Zepbound award reflects the company's continued role as a critical vendor in federal medical procurement, delivering diabetes medications and other pharmaceutical commodities to support Department of Defense healthcare requirements worldwide.
Quick answers
Who was awarded contract SPE2DB26FX3QT?
SPE2DB26FX3QT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FX3QT worth?
The government has obligated $52,298 on SPE2DB26FX3QT.
Is contract SPE2DB26FX3QT an order under another contract?
Yes. SPE2DB26FX3QT is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3QT competed?
The extent of competition for SPE2DB26FX3QT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award